By John Vandermosten, CFA NASDAQ: CRDF Key Opinion Leader Event Places Onvansertib in Context Cardiff Oncology, Inc. (NASDAQ: ...

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at ...

The analysis revealed that AI treatment significantly increased the incidence of hypertension (relative risk [RR], 3.28 [95% CI, 2.82–4.30]), myocardial ischemia or infarction events (RR, 2.09 [95% CI ...

Excessive signaling by platelet-derived growth factor receptor (PDGFR)-α, a transmembrane tyrosine kinase, helps drive the rapid angiogenesis that many types of tumor cells need in order to ...

Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...

Among the many forms of liver cancer, hepatocellular carcinoma (HCC) is the most common and one of the leading causes of cancer-related deaths worldwide. It is a complex disease with multiple ...

aDepartment of Public Health, University of Naples Federico II, Naples, Italy bDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy Tyrosine kinase inhibitors ...

A BRAF and EGFR inhibitor duo prolongs life in some patients with BRAF V600E-mutant metastatic colorectal cancer, according to results from the phase III BREAKWATER study presented at the 2025 ...